News for Covalon Technologies Ltd. (COV.V)

Revenue Growth: Strong revenue growth relative to prior periods, with sequential quarterly growth expected in Q3 and the second half of the year.Vascular Acces

May 28, 2025 / 12:30PM GMTOperator (technical difficulty) Good morning ladies and gentlemen, and welcome to the Covalon's Q2 fiscal 2025 conference call and web

Covalon Technologies Ltd (TSXV:COV) is set to release its Q2 2025 earnings on May 28, 2025. The consensus estimate for Q2 2025 revenue is $7.67 million, and the

Covalon Technologies Ltd. (COV, CVALF) announced promising clinical study results for VALGuard®, set for presentation at two major scientific meetings.

Covalon Technologies Ltd. (COV, CVALF) to release Q2 Fiscal 2025 results on May 28, 2025, before market opening. Conference call and webcast scheduled f

Covalon Technologies Ltd. (COV, CVALF) promotes Kim Crooks to Chief Operating Officer. Kim Crooks appointed to the Board of Directors, bringing extensiv

Covalon Technologies (TSXV: COV; OTCQX: CVALF) will present at the Planet MicroCap Showcase in Las Vegas on April 23, 2025, at 4:30 pm PST. The company

MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company is pleased to ann…

MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced …

MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced th…

Revenue: $8 million, representing a 75% year-on-year growth.Adjusted EBITDA: $1.5 million, a $2.9 million improvement over the previous year.Trailing 12 Months

Feb 21, 2025 / 01:30PM GMTOperator Good morning, ladies and gentlemen, and welcome to Covalon Technologies Ltd Q1 Cisco 2025 conference call and webcast. My nam

Covalon Technologies Ltd. (OTCQX:CVALF) Q1 2025 Earnings Conference Call February 21, 2025 8:30 AM ETCompany ParticipantsBrent Ashton - Chief Executive...

MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced …

MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to an…

**media[515644]**

Covalon Technologies Ltd. (OTCQX:CVALF) Q4 2024 Earnings Conference Call January 7, 2025 8:30 AM ETCompany ParticipantsBrent Ashton - CEOSaleha Assadzada -...

The following slide deck was published by Covalon Technologies Ltd.

Biocompatible Coatings Industry size is expected to register 9.4% CAGR between 2024 and 2032 propelled by increasing demand in healthcare industry....